IP Verse

A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors

EP2640413

OCTAPHARMA AG
Application Number
EP11784653A
Filing Date
Nov 16, 2011
Status
Opposition Rejected
Apr 28, 2023
Grant Date
Jun 12, 2019
External Links
Slate, Register

Biblio Summary

The patent EP2640413B1 was granted on Jun 12, 2019 by Octapharma Ag The patent is currently Opposition Rejected.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMAN LIMITEDMar 12, 2020WITHDRAWN

More Opposed Patents of Octapharma Ag

The table below shows the patents of Octapharma Ag that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3626737A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant FviiiNov 29, 20232
EP2707387A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant FviiiDec 25, 20191
EP2670429Method For Inactivation/Removal Of Coagulation Factors By PrecipitationApr 4, 20182

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents